Michigan gets $17.2M from settlement in drug discount case
Michigan is getting $17.2 million after drugmaker Pfizer Inc. agreed to resolve allegations that one of its companies failed to give Medicaid the same discounts it provided to private purchasers of a heartburn treatment.
Michigan Attorney General Bill Schuette on Wednesday detailed the state's portion of the settlement that totals nearly $785 million.
The tentative deal that resolves allegations filed by two whistleblowers was first announced in February, but final approval was announced Wednesday by the U.S. attorney's office in Boston.
The case involved alleged conduct by Wyeth before New York-based Pfizer acquired the company in 2009.
Under the terms of the settlement, the federal government will get more than $413 million. State Medicaid programs will share more than $371 million.